Mark Nakasone

Dr. Mark Nakasone is an Affiliate researcher at the School of Cancer Sciences, University of Glasgow, based at the Beatson Institute on the Garscube Estate. His research focuses on molecular mechanisms in cancer biology with particular emphasis on metabolic pathways and tumor suppressor mechanisms.

Dr. Nakasone's research interests span several key areas in cancer biology including:

• Molecular mechanisms of tumor suppression
• Cancer metabolism, particularly glutamine-related pathways
• Protein-protein interactions in cancer signaling pathways
• Molecular regulation of metabolic enzymes in cancer

His recent publications demonstrate expertise in both cancer metabolism and molecular tumor suppressor mechanisms. The 2023 publication in Nature Chemical Biology explores hepatic glutamine synthetase and its role in controlling N5-methylglutamine in both normal homeostasis and cancer contexts. The 2022 publication in Life Science Alliance investigates the molecular interaction between p14ARF and MDM2, revealing how this binding inhibits E3 ligase function - a critical process in cancer development.

Dr. Nakasone collaborates with researchers across institutions as evidenced by his co-authorship with scientists from various backgrounds. His work appears in high-impact journals in the cancer and molecular biology fields.